Systemic SP-D was recently demonstrated to be decreased in type II diabetes, positively associated with insulin sensitivity after oral glucose tolerance test [8] and negatively associated with obesity [9], [10]. Here, SFTPD is linked to obesity due to melanocortin 4 receptor deficiency.